samedan logo
 
 
spacer
home > pmps > summer 2019 > redefining supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Redefining Supply

Passive packaging is coming of age. In a world where door-to-door delivery is transforming the consumer experience, more and more sectors are waking up to the possibilities of delivering temperature-controlled products in a simple, cost-effective, and reliable way.

As the world faces the challenges of global warming, new approaches to packaging also provide opportunities to reassess the impact of supply chains on the planet. However, while industries such as retail and food have been quick to adopt new forms of delivery, they do so without the strict regulations and restraints that often apply to the pharmaceutical sector.

As Managing Director of a company that has invested millions in R&D for passive packaging solutions, I am well aware of both the challenges and benefits they can bring to pharma customers, and, as a passionate believer in the properties of natural materials, I appreciate the particular challenges a more ecological packaging approach presents to this most scientific of sectors.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Josie Morris BA (Hons), MA, is Managing Director at The Wool Packaging Company Ltd (Woolcool). A passionate advocate for diversity and the development of strong cultures within innovative businesses, Josie is also closely involved with organisations such as the Bio-Based Industries Association (BBIA), which lobby the UK government on the environmental problems of global packaging waste and support pioneering companies such as Woolcool that offer genuinely sustainable alternatives to plastic materials.
spacer
josie@woolcool.com
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS CoV 2 Vaccine Based on Proprietary ASC Technology

Istanbul, Turkey, 6 July 2022: Life Science Newswire Vaccizone, a vaccine development company focusing on innovative antigen delivery technology, selected Exothera S.A. to fast-track process development of its SARS CoV 2 vaccine for European clinical trials.
More info >>

White Papers

Successfully managing the unique demands of cell therapy supply chains

PCI Pharma Services

Cell therapy professionals joined a specialist webinar by industry experts from PCI Clinical Services and TrakCel, addressing the unique complexity of an autologous therapy supply chain. Hosted by European Pharmaceutical Manufacturer magazine, the webinar was delivered by Rachel Griffiths, Associate Director, Technical Services, PCI Clinincal Services, and Dr. Matthew Lakelin, Vice President, Scientific Affairs and Business Development, TrakCel . Here, we present the white paper from that webinar event.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement